GlassScriptPhysician profile
Miriam Korik
NPI 1114544954
$7,350.22
in general payments reported to CMS, 2019-2025
19 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,644 · 2022: $1,455 · 2023: $835 · 2024: $1,607 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $941.47 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $878.28 | 2021-2025 | Precision7, Precision 1, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $860.64 | 2021 | |
| Coopervision INC. | $684.81 | 2023-2025 | Myday Contact Lens, Misight Contact Lens, Ortho-K Contact Lens |
| Johnson & Johnson Vision Care, INC. | $523.24 | 2022-2025 | Acuvue |
| Abbvie INC. | $518.21 | 2023-2024 | |
| Glaukos Corporation | $510.25 | 2022-2024 | Kxl System (Not Refurbished), Radius |
| Lumenis Be INC | $426.90 | 2025 | Optilight |
| Allergan, INC. | $395.21 | 2022 | |
| Sun Pharmaceutical Industries INC. | $368.29 | 2021-2025 | |
| Sight Sciences, INC. | $339.26 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $282.35 | 2021 | |
| Rxsight INC | $147.20 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $144.51 | 2025 | |
| Dompe US, INC. | $125.00 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $83.33 | 2024 | |
| Horizon Therapeutics Plc | $66.16 | 2023 | |
| Visioneering Technologies, INC. | $39.69 | 2021 | |
| Biotissue Holdings INC. | $15.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Korik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.